Analytica Limited has appointed biotech industry veteran Carl Stubbings as a non-executive director, contributing his considerable skills of international marketing, strategic planning and commercialisation. He will commence in the role on 13 January. Mr. Stubbings' experience in the sector spans over 30 years with a focus on medical diagnostics as well as biotechnology.

He has specialised in sales with a particular emphasis on marketing across North America, Latin America, Asia Pacific and Europe as well as roles covering manufacturing and administration. Currently focussed on developing and executing the commercialisation strategy including licensing and partnership agreements, Mr. Stubbings' position as chief business officer at ASX- listed Benitec Biopharma Limited also sees him responsible for managing shareholder and investor relations. Mr. Stubbings is also currently a non-executive director of unlisted public company Sienna Diagnostics, providing strategic direction for the company's high performing cancer diagnostic test.